Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial Monday December 4, 7:00 am ET - New drug application planned for mid-2007 - PALO ALTO, Calif. and DEERFIELD, Ill., Dec. 4 -- CV ...
San Francisco, CA—Regadenoson yielded similar Fractional Flow Reserve (FFR) measurements as adenosine in a cohort of patients with angiographic CAD. Lokien van Nunen MD, of Catharina Hospital ...
Discover comprehensive details about Regadenoson, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
Review the side-effects of Regadenoson as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Clinicians should avoid using the imaging agents regadenoson (Lexiscan, Astellas Pharma US) and adenosine (Adenoscan, Astellas Pharma US) for cardiac nuclear stress tests of patients with signs or ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 24, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New ...
Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. Hikma is offering Regadenoson ...
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a Henry Ford Hospital ...
A phase II study of the combination of BKM120 (buparlisib) and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM). This is an ASCO Meeting Abstract from the 2015 ASCO ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) for additional imaging modalities for its stress agent ...
The company said its current portfolio consists of 172 products authorized for distribution in the US marketplace and 47 abbreviated new drug applications (ANDAs) pending approval with the USFDA.
The drug regadenoson is safe and poses fewer side effects than the conventional medication used during a cardiac nuclear stress test of heart transplant patients, according to a new study. Researchers ...